Medical and procedural treatment of androgenetic alopecia - Where are we?

J Am Acad Dermatol. 2023 Aug;89(2S):S36-S39. doi: 10.1016/j.jaad.2023.05.004.

Abstract

Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.

Keywords: androgenetic alopecia; finasteride; hair loss; hair transplantation; minoxidil; platelet-rich plasma.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alopecia* / drug therapy
  • Behavior Therapy
  • Dietary Supplements
  • Finasteride* / therapeutic use
  • Humans
  • Minoxidil / therapeutic use

Substances

  • Finasteride
  • Minoxidil